News

The Return of Scarlet Fever?

Research has emerged showing a growing rate of scarlet fever in China and the United Kingdom in the past few years.


 

Is scarlet fever—long thought to be eradicated—reemerging as a health threat? China, the United Kingdom, and Hong Kong have seen upsurges in scarlet fever cases in the past few years.

[embed:render:related:node:142089]

Hong Kong has seen a more than 10-fold increase over the previous incidence rate. In a study of 7,266 patients aged ≤ 14 years (3,304 with laboratory-confirmed diagnosis), researchers from University of Hong Kong found a “sharp peak” in 2011: 1,438 cases were reported, exceeding the total number of 1,117 in the previous 6 years. Since then, the annual number of reported cases has remained at a “relatively high level,” the researchers say, with an average of 14.5 cases per 10,000 children during 2012-2015.

The elevated pattern was more apparent in children aged ≤ 5 years. In that age group, annual incidence averaged 3.3 per 10,000 during 2005-2010, then jumped dramatically to 23.9 per 10,000 in 2011. It dropped slightly to 18.1 per 10,000 in 2012-2015.

The cause is unclear, the researchers say. They cite 1 report that suggests toxin acquisition and multidrug resistance may have contributed. School is probably a major transmission site. Incidence was higher among younger children entering school and during school days. The researchers say boys were more at risk than girls, possibly because they have more physical interactions or poorer personal hygiene. Thus, school-based control measures—especially for boys aged 3 to 5 years—could be “particularly important.”

Recommended Reading

The Role of Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Swabs in Clinical Decision Making
Federal Practitioner
Collaboration of the NIH and PHS Commissioned Corps in the International Ebola Clinical Research Response
Federal Practitioner
Social Interaction May Enhance Patient Survival After Chemotherapy
Federal Practitioner
Legionnaires’ Disease in Health Care Settings
Federal Practitioner
Florence A. Blanchfield: A Lifetime of Nursing Leadership
Federal Practitioner
Keeping Up-to-Date on Health Disparity Data
Federal Practitioner
A Case of Streptococcus pyogenes Sepsis of Possible Oral Origin
Federal Practitioner
Cannabinoid Hyperemesis Syndrome
Federal Practitioner
Multiple Comorbidities: Does Age Matter?
Federal Practitioner
Getting Creative About Reducing Kidney Stones
Federal Practitioner

Related Articles